GSK72_79 205419 Safety and Immunogenicity Study of GSK Meningococcal Group B Vaccine Bexsero (GSK3536829A) when Administered Concomitantly with GSK Meningococcal MenACWY Conjugate Vaccine Menveo (GSK3536820A) to Healthy Subjects 16-18 Years of Age